Table 2 Kinetic parameters for subtilisin specific fluoroprobes 6, 6a
and 6e. Kinetic constants for the AMC standard 7 were taken from
ref. 10
Fluoroprobes
KM/mM
kcat/sÀ1
kcat/KM/MÀ1 sÀ1
6
0.136 Æ 0.021
0.241 Æ 0.037
0.263 Æ 0.014
0.740
0.087 Æ 0.005
0.086 Æ 0.011
0.189 Æ 0.005
0.65
650 Æ 62
359 Æ 10
720 Æ 19
880
6a
6e
7
Table S1, ESIw). However, this decrease in Frel is accompanied
by significant bathochromic shifts of the excitation and
emission maxima as well as an extended Stokes shift, which
aids utility of the fluorogenic substrate.
To determine if the introduction of 3-(hetero)aryl-substituents
in the ACA structure has an effect on the enzyme–substrate
interaction, we carried out enzyme kinetic measurements
(Table 2). Compared to the AMC-based substrate 7,10 the three
ACA substrates are characterized by lower KM and kcat values.
However, among the ACA substrates, 6e stands out due to a
higher kcat value and a kcat/KM value that is similar to 7. These
findings together with the feature of having red shifted lmax and
lex highlight the significant utility of our green fluorophore
5e and its corresponding fluorogenic substrate 6e for bio-imaging.
To obtain the PRNs, the fluorogenic peptides 6 and 6e were
tethered to amine-functionalized nanoparticles using a stan-
dard DIC/HOAt coupling procedure. The nanoparticles de-
rived from acrylamide and N-(3-aminopropyl)methacrylamide
were prepared via an inverse microemulsion polymerization
process, which is known to produce nm-sized particles with a
narrow size distribution.14 Characterization by dynamic light
scattering (DLS) showed that the nanoparticles were on
average approximately 47 nm in diameter (Fig. 5a).
Fig. 5 (a) DLS of polyacrylamide nanoparticles (NPs); (b) subtilisin
mediated cleavage reaction of NP-bound 6e (lex
= 430 nm);
(c) enzyme kinetic of NP-bound 6e at different subtilisin con-
centrations; (d) initial velocity (v0) versus subtilisin concentration of
NP-bound 6 and 6e.
tunable PRN should find application in diagnostics and high-
throughput screening of protease inhibitors. We are currently
determining the general utility of different configurations of
bio-imaging agents based on our new bifunctional green
fluorescent coumarin dye, especially in a cellular and in vivo
context.
KW would like to acknowledge Engineering & Physical
Sciences Research Council and Royal Society of Chemistry,
UK for the funding of an analytical science studentship.
Notes and references
Proof of principle for the concept of PRN was indeed
confirmed by a significant increase in fluorescence when the
nanoprobe was incubated with subtilisin at 37 1C in Tris–HCl
buffer (pH = 8.20) (Fig. 5b). The enzyme reaction slowed
after 10 minutes, indicating a fast initial protease response
(Fig. 5c). In fact, after 10 minutes, ca. 80-fold rise in the
fluorescence signal was observed when subtilisin was present at
10 mM. A linear relationship between the initial velocity of
nanoparticle-bound 6 and 6e and subtilisin concentration was
observed up to a measured enzyme concentration of 10 mM
(Fig. 5d). With initial rates three times as high, PRN com-
prising 6e are better enzyme substrates than 6-derived PRN.
These findings are in agreement with our initial enzyme kinetic
results outlined in Table 2. Control experiments revealed that
no significant change in the fluorescence was observed in
the absence of subtilisin or in the presence of chymotrypsin.
The concept presented here is modular and hence can easily be
extended to other endopeptidases by choosing the appropriate
substrates (e.g., see Fig. S4, ESIw).
1 A. Baruch, D. A. Jeffery and M. Bogyo, Trends Cell Biol., 2004, 14, 29.
2 I. L. Medintz, A. R. Clapp, F. M. Brunel, T. Tiefenbrunn,
H. T. Uyeda, E. L. Chang, J. R. Deschamps, P. E. Dawson and
H. Mattoussi, Nat. Mater., 2006, 5, 581.
3 M. Zhou and I. Ghosh, Pept. Sci., 2007, 88, 325.
4 M. Funovics, R. Weissleder and C. H. Tung, Anal. Bioanal. Chem.,
2003, 377, 956.
5 J. W. Aylott, Analyst, 2003, 128, 309.
6 A. Watzke, G. Kosec, M. Kindermann, V. Jeske, H. P. Nestler,
V. Turk, B. Turk and K. U. Wendt, Angew. Chem., Int. Ed., 2008,
47, 406.
7 B. Turk, Nat. Rev. Drug Discovery, 2006, 5, 785.
8 (a) D. J. Maley, F. Leonetti, J. Backes, D. S. Dauber, J. L. Harris,
C. S. Craik and J. A. Ellman, J. Org. Chem., 2002, 67, 910;
(b) J. L. Harris, B. J. Backes, F. Leonetti, S. Mahrus,
J. A. Ellman and C. S. Craik, Proc. Natl. Acad. Sci. U. S. A.,
2000, 97, 7754.
9 M. S. Schiedel, C. A. Briehn and P. Bauerle, Angew. Chem., Int.
Ed., 2001, 40, 4677.
¨
10 Y. Kanaoka, T. Takahashi, H. Nakayama and K. Tanizawa,
Chem. Pharm. Bull., 1985, 33, 1721.
11 J. Deere, G. McConnell, A. Lalaouni, B. A. Maltman, S. L. Flitsch
and P. J. Halling, Adv. Synth. Catal., 2007, 349, 1321.
12 Q. Zhu, D. B. Li, M. Uttamchandani and S. Q. Yao, Bioorg. Med.
Chem. Lett., 2003, 13, 1033.
13 Fmoc Solid Phase Peptide Synthesis: A Practical Approach, ed.
W. C. Chan and P. D. White, Oxford University Press, Oxford,
2000.
14 Surfactants and Polymers in Aqueous Solution, ed. K. Holmberg,
B. Jonsson, B. Kronberg and B. Lindman, John Wiley & Sons,
¨
In conclusion, using rational design principles we have
synthesized a new family of fluorescence-based PRNs for the
efficient detection of protease activity. These devices consist of
a nanoparticle that is covalently attached to fluorogenic pep-
tide substrates comprising spectrofluorimetrically improved
bifunctionalized 3-arylcoumarin (5e). These customized and
Chichester, 2003.
ꢀc
This journal is The Royal Society of Chemistry 2009
Chem. Commun., 2009, 671–673 | 673